Biotech · Private company
CytoSorbents, Inc
Track this companyFree. Adds CytoSorbents, Inc to your Dealase workspace and tells you when its record changes.
Clinical trials60 recruiting or active
Pipeline programs6From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline6
- CVVHPhase 2 · RhabdomyolysisClinicalTrials.gov · fetched Nov 12, 2026
- CytoSorb DevicePhase 2 · RhabdomyolysisClinicalTrials.gov · fetched Nov 12, 2026
- CytoSorbElective Cardiac SurgeryClinicalTrials.gov · fetched Nov 12, 2026
- CytoSorb 300 mL deviceCOVID-19ClinicalTrials.gov · fetched Nov 12, 2026
- DrugSorb-ATR systemHemorrhage, SurgicalClinicalTrials.gov · fetched Nov 12, 2026
- Sham comparatorHemorrhage, SurgicalClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials6
- Safe and Timely Antithrombotic Removal - Direct Oral Anticoagulants Apixaban & Rivaroxaban (STAR-D)NA · TERMINATED · started Dec 27, 2021ClinicalTrials.gov NCT05093504 · fetched Nov 12, 2026
- Safe and Timely Antithrombotic Removal - Ticagrelor (STAR-T)NA · COMPLETED · started Aug 31, 2021ClinicalTrials.gov NCT04976530 · fetched Nov 12, 2026
- Registry of CytoSorb Therapy in COVID-19 ICU PatientsCOMPLETED · started Aug 28, 2020ClinicalTrials.gov NCT04391920 · fetched Nov 12, 2026
- CytoSorb® Reduction of FREee Hemoglobin/Acute Kidney Injury (AKI) During Cardiac SurgeryNA · TERMINATED · started Apr 19, 2018ClinicalTrials.gov NCT03384875 · fetched Nov 12, 2026
- CytoSorb Reduction of Free Hemoglobin During Cardiac SurgeryNA · COMPLETED · started Nov 1, 2015ClinicalTrials.gov NCT02566525 · fetched Nov 12, 2026
- Extracorporeal Therapy for the Removal of Myoglobin Using the CytoSorb in Patients With RhabdomyolysisPHASE2 · WITHDRAWN · started Mar 1, 2014ClinicalTrials.gov NCT02111018 · fetched Nov 12, 2026